We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

400 hedge funds and large institutions have $6.44B invested in United Therapeutics in 2017 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 135 increasing their positions, 139 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 32

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

26% more capital invested

Capital invested by funds: $5.13B → $6.44B (+$1.31B)

7% more funds holding

Funds holding: 373 → 400 (+27)

0.49% more ownership

Funds ownership: 100.54% → 101.03% (+0.49%)

3% less repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 139

11% less call options, than puts

Call options by funds: $20.4M | Put options by funds: $23M

Holders
400
Holders Change
+27
Holders Change %
+7.24%
% of All Funds
9.07%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
62
Increased
135
Reduced
139
Closed
32
Calls
$20.4M
Puts
$23M
Net Calls
-$2.55M
Net Calls Change
-$45.6M

Top Buyers

1
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$47.1M
2
WCM
Wedge Capital Management
North Carolina
+$39.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$24.4M
4
Renaissance Technologies
Renaissance Technologies
New York
+$24.1M
5
Fidelity International
Fidelity International
Bermuda
+$20.8M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$43.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.4M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$31.4M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$24.2M
5
State Street
State Street
Massachusetts
-$21.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
101
Allianz Asset Management
Germany
$5.96M -$5.56M -43,751 -52%
DSAM
102
Dock Street Asset Management
Florida
$5.93M +$498K +3,921 +11%
CA
103
Commerzbank Aktiengesellschaft
Germany
$5.89M – – –
JG
104
Jefferies Group
New York
$5.67M +$4.87M +38,332 New
Janus Henderson Group
105
Janus Henderson Group
United Kingdom
$5.57M -$1.13M -8,920 -19%
MOACM
106
Mutual of America Capital Management
New York
$5.43M +$87.1K +685 +2%
HighTower Advisors
107
HighTower Advisors
Illinois
$5.33M +$442K +3,478 +11%
VOYA Investment Management
108
VOYA Investment Management
Georgia
$5.19M +$2.93M +23,045 +192%
PCM
109
Portolan Capital Management
Massachusetts
$5.06M -$1.52M -11,962 -26%
NAP
110
New Amsterdam Partners
New York
$5.01M -$112K -882 -3%
OPERF
111
Oregon Public Employees Retirement Fund
Oregon
$4.95M -$21.4K -168 -0.5%
T
112
TOBAM
France
$4.77M -$4.47M -35,156 -52%
Comerica Bank
113
Comerica Bank
Texas
$4.72M +$7.12K +56 +0.2%
TCM
114
Twin Capital Management
Pennsylvania
$4.66M +$146K +1,150 +4%
ASRS
115
Arizona State Retirement System
Arizona
$4.6M +$824K +6,480 +26%
Baird Financial Group
116
Baird Financial Group
Wisconsin
$4.44M +$29.1K +229 +0.8%
FNBOO
117
First National Bank of Omaha
Nebraska
$4.41M – – –
TPSF
118
Texas Permanent School Fund
Texas
$4.32M -$318K -2,505 -8%
Squarepoint
119
Squarepoint
New York
$4.28M +$2.33M +18,344 +173%
ProShare Advisors
120
ProShare Advisors
Maryland
$4.17M -$12.7K -100 -0.4%
Rafferty Asset Management
121
Rafferty Asset Management
New York
$4.06M +$3.49M +27,456 New
MIM
122
MetLife Investment Management
New Jersey
$4.04M +$3.48M +27,340 New
SCA
123
Sage Capital Advisors
South Dakota
$3.99M +$19.3K +152 +0.6%
AIM
124
Assured Investment Management
New York
$3.92M -$6.47M -50,856 -66%
SSCM
125
Summit Street Capital Management
New York
$3.86M – – –
3 4
5
6 7

UTHR Hedge Fund Activity: Q4 2017 in Review

400 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2017, worth a combined $6.44B — up 26% from $5.13B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new UTHR positions and 32 closed out — a net gain of 30 holders — while 135 added to existing stakes and 139 trimmed.

The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $47.1M. The largest seller was Morgan Stanley, cutting an estimated $43.6M.

  • 400 institutional investors held United Therapeutics (UTHR) as of Q4 2017, up from 373 in Q3 2017.
  • Funds reported $6.44B of United Therapeutics stock for Q4 2017, up 26% quarter-over-quarter.
  • 62 funds opened new United Therapeutics positions in Q4 2017 and 32 closed out, a net change of +30 holders.
  • The largest United Therapeutics buyer in Q4 2017 was Skandinaviska Enskilda Banken (SEB), an estimated $47.1M added.
  • The largest United Therapeutics seller in Q4 2017 was Morgan Stanley, an estimated $43.6M sold.

Based on aggregated 13F filings for Q4 2017.